Literature DB >> 19530939

Dengue virus infection differentially regulates endothelial barrier function over time through type I interferon effects.

Ping Liu1, Marcia Woda, Francis A Ennis, Daniel H Libraty.   

Abstract

BACKGROUND: The morbidity and mortality resulting from dengue hemorrhagic fever (DHF) are largely caused by endothelial barrier dysfunction and a unique vascular leakage syndrome. The mechanisms that lead to the location and timing of vascular leakage in DHF are poorly understood. We hypothesized that direct viral effects on endothelial responsiveness to inflammatory and angiogenesis mediators can explain the DHF vascular leakage syndrome.
METHODS: We used an in vitro model of human endothelium to study the combined effects of dengue virus (DENV) type 2 (DENV2) infection and inflammatory mediators on paracellular macromolecule permeability over time.
RESULTS: Over the initial 72 h after infection, DENV2 suppressed tumor necrosis factor (TNF)-alpha-mediated hyperpermeability in human umbilical vein endothelial cell (HUVEC) monolayers. This suppressive effect was mediated by type I interferon (IFN). By 1 week, TNF-alpha stimulation of DENV2-infected HUVECs synergistically increased cell cycling, angiogenic changes, and macromolecule permeability. This late effect could be prevented by the addition of exogenous type I IFN.
CONCLUSIONS: DENV infection of primary human endothelial cells differentially modulates TNF-alpha-driven angiogenesis and hyperpermeability over time. Type I IFN plays a central role in this process. Our findings suggest a rational model for the DHF vascular leakage syndrome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19530939      PMCID: PMC3881588          DOI: 10.1086/599795

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  48 in total

1.  Identification of genes selectively regulated by IFNs in endothelial cells.

Authors:  Stefano Indraccolo; Ulrich Pfeffer; Sonia Minuzzo; Giovanni Esposito; Valeria Roni; Susanna Mandruzzato; Nicoletta Ferrari; Luca Anfosso; Raffaella Dell'Eva; Douglas M Noonan; Luigi Chieco-Bianchi; Adriana Albini; Alberto Amadori
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

Review 2.  Dengue.

Authors:  Scott B Halstead
Journal:  Lancet       Date:  2007-11-10       Impact factor: 79.321

3.  Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF.

Authors:  Gangjian Qin; Raj Kishore; Christine M Dolan; Marcy Silver; Andrea Wecker; Corinne N Luedemann; Tina Thorne; Allison Hanley; Cynthia Curry; Lindsay Heyd; Deepika Dinesh; Marianne Kearney; Fabio Martelli; Toshinori Murayama; David A Goukassian; Yan Zhu; Douglas W Losordo
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-11       Impact factor: 11.205

4.  Influenza virus evades innate and adaptive immunity via the NS1 protein.

Authors:  Ana Fernandez-Sesma; Svetlana Marukian; Barbara J Ebersole; Dorothy Kaminski; Man-Seong Park; Tony Yuen; Stuart C Sealfon; Adolfo García-Sastre; Thomas M Moran
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  Dengue-virus-infected dendritic cells trigger vascular leakage through metalloproteinase overproduction.

Authors:  Natthanej Luplertlop; Natthanej Luplerdlop; Dorothée Missé; Dorothy Bray; Virginie Deleuze; Jean-Paul Gonzalez; Vijittra Leardkamolkarn; Hans Yssel; Francisco Veas
Journal:  EMBO Rep       Date:  2006-10-06       Impact factor: 8.807

Review 6.  APC-derived cytokines and T cell polarization in autoimmune inflammation.

Authors:  Ilona Gutcher; Burkhard Becher
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

Review 7.  A cytokine-mediated link between innate immunity, inflammation, and cancer.

Authors:  Wan-Wan Lin; Michael Karin
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

8.  Tropism of dengue virus in mice and humans defined by viral nonstructural protein 3-specific immunostaining.

Authors:  Scott J Balsitis; Josefina Coloma; Glenda Castro; Aracely Alava; Diana Flores; James H McKerrow; P Robert Beatty; Eva Harris
Journal:  Am J Trop Med Hyg       Date:  2009-03       Impact factor: 2.345

9.  Doxycycline induces membrane expression of VE-cadherin on endothelial cells and prevents vascular hyperpermeability.

Authors:  Ofer Fainaru; Irit Adini; Ofra Benny; Lauren Bazinet; Elke Pravda; Robert D'Amato; Judah Folkman
Journal:  FASEB J       Date:  2008-07-07       Impact factor: 5.191

10.  Activation of endothelial cells, coagulation and fibrinolysis in children with Dengue virus infection.

Authors:  Darintr Sosothikul; Panya Seksarn; Sureeporn Pongsewalak; Usa Thisyakorn; Jeanne Lusher
Journal:  Thromb Haemost       Date:  2007-04       Impact factor: 5.249

View more
  22 in total

1.  Dengue virus infection of mast cells triggers endothelial cell activation.

Authors:  Michael G Brown; Laura L Hermann; Andrew C Issekutz; Jean S Marshall; Derek Rowter; Ayham Al-Afif; Robert Anderson
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

Review 2.  Immune-mediated cytokine storm and its role in severe dengue.

Authors:  Anon Srikiatkhachorn; Anuja Mathew; Alan L Rothman
Journal:  Semin Immunopathol       Date:  2017-04-11       Impact factor: 9.623

Review 3.  Endothelial cells in dengue hemorrhagic fever.

Authors:  Anon Srikiatkhachorn; James F Kelley
Journal:  Antiviral Res       Date:  2014-07-12       Impact factor: 5.970

4.  Lymphatic Type 1 Interferon Responses Are Critical for Control of Systemic Reovirus Dissemination.

Authors:  Matthew B Phillips; Marcelle Dina Zita; Morgan A Howells; Tiffany Weinkopff; Karl W Boehme
Journal:  J Virol       Date:  2021-01-28       Impact factor: 5.103

5.  Differential regulation of angiopoietin 1 and angiopoietin 2 during dengue virus infection of human umbilical vein endothelial cells: implications for endothelial hyperpermeability.

Authors:  Siew Pei Ong; Mah Lee Ng; Justin Jang Hann Chu
Journal:  Med Microbiol Immunol       Date:  2013-08-30       Impact factor: 3.402

6.  DENV NS1 and MMP-9 cooperate to induce vascular leakage by altering endothelial cell adhesion and tight junction.

Authors:  Pan Pan; Geng Li; Miaomiao Shen; Zhenyang Yu; Weiwei Ge; Zizhao Lao; Yaohua Fan; Keli Chen; Zhihao Ding; Wenbiao Wang; Pin Wan; Muhammad Adnan Shereen; Zhen Luo; Xulin Chen; Qiwei Zhang; Luping Lin; Jianguo Wu
Journal:  PLoS Pathog       Date:  2021-07-26       Impact factor: 6.823

Review 7.  Cardiovascular manifestations of the emerging dengue pandemic.

Authors:  Sophie Yacoub; Heiman Wertheim; Cameron P Simmons; Gavin Screaton; Bridget Wills
Journal:  Nat Rev Cardiol       Date:  2014-04-08       Impact factor: 32.419

8.  Dengue virus type 2 modulates endothelial barrier function through CD73.

Authors:  Chinmay Patkar; Kris Giaya; Daniel H Libraty
Journal:  Am J Trop Med Hyg       Date:  2012-11-13       Impact factor: 2.345

Review 9.  Pathogenesis of vascular leak in dengue virus infection.

Authors:  Gathsaurie Neelika Malavige; Graham S Ogg
Journal:  Immunology       Date:  2017-05-24       Impact factor: 7.397

10.  Development of a transmission model for dengue virus.

Authors:  Rebecca C Christofferson; Michael K McCracken; Ann-Marie Johnson; Daniel M Chisenhall; Christopher N Mores
Journal:  Virol J       Date:  2013-04-23       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.